Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1222.2
(-1.95%)
INR 1222.2
(-1.95%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.51 Billion | 13.4 Billion | 12.89 Billion | 9.79 Billion | 8.06 Billion | 3.66 Billion |
| Cost of Revenue | 6.39 Billion | 5.85 Billion | 5.55 Billion | 4.2 Billion | 3.24 Billion | 1.51 Billion |
| Gross Profit | 4.12 Billion | 7.54 Billion | 7.34 Billion | 5.59 Billion | 4.82 Billion | 2.15 Billion |
| Operating Expenses | 1.4 Billion | 2.36 Billion | 1.91 Billion | 1.48 Billion | 1.2 Billion | 520.87 Million |
| Selling, General and Administrative Expenses | 1.4 Billion | 1.1 Billion | 368.67 Million | 265.76 Million | 264.34 Million | 135.37 Million |
| Research and Development Expenses | - | 85.85 Million | 103.54 Million | 110.57 Million | 141.31 Million | - |
| Other Expenses | - | 463.63 Million | 14.7 Million | 10.48 Million | 2.58 Million | 390.24 Million |
| Cost and Expenses | 5.9 Billion | 8.21 Billion | 7.46 Billion | 5.68 Billion | 4.45 Billion | 2.03 Billion |
| Operating Income | 4.6 Billion | 5.18 Billion | 5.41 Billion | 4.09 Billion | 3.58 Billion | 3.9 Billion |
| Interest Expense | 74.51 Million | 54.36 Million | 62.35 Million | 91.43 Million | 199.15 Million | 17.18 Million |
| Income Tax Expense | 1.05 Billion | 1.48 Billion | 2.13 Billion | 1.05 Billion | 875.1 Million | 485.92 Million |
| Earnings before Tax | 4.05 Billion | 5.59 Billion | 6.67 Billion | 4.67 Billion | 4.04 Billion | 1.57 Billion |
| Net Income | 3 Billion | 4.11 Billion | 4.53 Billion | 3.62 Billion | 3.17 Billion | 1.09 Billion |
| Earnings Per Share Basic | 11.80 | 16.16 | 17.83 | 14.23 | 6.23 | 4.29 |
| Earnings Per Share Diluted | 11.80 | 16.16 | 17.83 | 14.23 | 6.23 | 4.29 |
| Weighted Average Shares Outstanding | 254.47 Million | 254.56 Million | 254.56 Million | 254.56 Million | 509.13 Million | 254.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 254.56 Million | 254.56 Million | 254.56 Million | 254.56 Million | 509.13 Million | 254.56 Million |
| Gross Margin | 0.39 | 0.56 | 0.57 | 0.57 | 0.60 | 0.59 |
| EBIT Margin | 0.44 | 0.46 | 0.50 | 0.52 | 0.55 | 0.47 |
| Profit Margin | 0.29 | 0.31 | 0.35 | 0.37 | 0.39 | 0.30 |
| EBITDA | 4.67 Billion | 6.2 Billion | 6.74 Billion | 4.56 Billion | 4 Billion | 1.72 Billion |
| Earnings Before Tax Margin | 0.44 | 0.39 | 0.42 | 0.42 | 0.44 | 1.07 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.3 Billion | 10.51 Billion | 2.52 Billion | 2.19 Billion | 2.31 Billion | 3.47 Billion |
| Cost of Revenue | 1.49 Billion | 6.39 Billion | 1.76 Billion | 1.05 Billion | 868.81 Million | 1.33 Billion |
| Gross Profit | 809.9 Million | 4.12 Billion | 760.36 Million | 1.14 Billion | 1.44 Billion | 2.14 Billion |
| Operating Expenses | 144.6 Million | 611.09 Million | 199.38 Million | 622.85 Million | 581.02 Million | 595.78 Million |
| Selling, General and Administrative Expenses | -77.4 Million | - | 199.38 Million | 144.18 Million | 131.59 Million | 287.44 Million |
| Research and Development Expenses | 222 Million | - | 22.75 Million | 22.82 Million | 44.73 Million | 20.88 Million |
| Other Expenses | 181.6 Million | 619.05 Million | 170.53 Million | 143.44 Million | 198.41 Million | 106.65 Million |
| Cost and Expenses | 1.64 Billion | 7 Billion | 1.96 Billion | 1.67 Billion | 1.44 Billion | 1.93 Billion |
| Operating Income | 665.3 Million | 3.51 Billion | 560.97 Million | 667.37 Million | 1.05 Billion | 1.54 Billion |
| Interest Expense | 16 Million | 74.51 Million | 45.32 Million | 12.69 Million | 5.02 Million | 11.46 Million |
| Income Tax Expense | 223.2 Million | 1.05 Billion | 174.78 Million | 187.14 Million | 258.44 Million | 433.53 Million |
| Earnings before Tax | 830.9 Million | 4.05 Billion | 708.51 Million | 654.68 Million | 1.05 Billion | 1.63 Billion |
| Net Income | 607.7 Million | 3 Billion | 533.73 Million | 467.53 Million | 795.64 Million | 1.2 Billion |
| Earnings Per Share Basic | 2.39 | - | 2.10 | 1.84 | 3.13 | 4.74 |
| Earnings Per Share Diluted | 2.39 | - | 2.10 | 1.84 | 3.13 | 4.74 |
| Weighted Average Shares Outstanding | 254.56 Million | 254.47 Million | 254.56 Million | 254.56 Million | 254.56 Million | 254.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 254.56 Million | 254.47 Million | 254.56 Million | 254.56 Million | 254.56 Million | 254.56 Million |
| Gross Margin | 0.35 | 0.39 | 0.30 | 0.52 | 0.62 | 0.62 |
| EBIT Margin | 0.35 | - | 0.29 | 0.36 | 0.51 | 0.51 |
| Profit Margin | 0.26 | 0.29 | 0.21 | 0.21 | 0.34 | 0.35 |
| EBITDA | 799.3 Million | - | 733.43 Million | 794.89 Million | 1.17 Billion | 1.77 Billion |
| Earnings Before Tax Margin | 0.29 | 0.33 | 0.22 | 0.30 | 0.46 | 0.44 |
NLLSF
PLNK
BGOPF
AKASH
XAIR
688335